Wyeth says generic Effexor registration ‘not legitimate’
Article
2018-06-05 10:14 pm
| Sydney
Three generic drug manufacturers cannot claim damages for an injunction barring the release of cheaper versions of Effexor-XR, even if the injunction was later overturned, pharmaceutical giant Wyeth told a judge on day two of a six-week trial over its blockbuster antidepressant.
For information on rights and reprints, contact subscriptions@lawyerly.com.au